X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
1. Arubendol
2. Asthmoprotect
3. Brethaire
4. Brethine
5. Bricanyl
6. Bricanyl Sa
7. Butaliret
8. Butalitab
9. Contimit
10. Kwd 2019
11. Kwd-2019
12. Kwd2019
13. Monovent
14. Taziken
15. Tedipulmo
16. Terbasmin
17. Terbul
18. Terbutalin Al
19. Terbutalin Ratiopharm
20. Terbutalin Stada
21. Terbutalin Von Ct
22. Terbutalin-ratiopharm
23. Terbutaline
24. Terbutaline Sulfate
25. Terbuturmant
1. Terbutaline Solution
2. Terbutaline (sulfate)
3. Mls000069693
4. Smr000058516
5. Kwd-2019
6. Sr-01000000174
7. Opera_id_498
8. Schembl41870
9. Mls001148384
10. Spectrum1500558
11. Chembl1160544
12. Regid_for_cid_657301
13. Hms500d20
14. Hms1921c15
15. Hms2092k19
16. Hms2231h10
17. Hms3259j05
18. Hms3372i16
19. Pharmakon1600-01500558
20. Ccg-39265
21. Nsc757336
22. Akos015960700
23. Nc00619
24. Ncgc00094789-01
25. Ncgc00094789-02
26. Ncgc00094789-03
27. Ncgc00094789-04
28. Ac-12158
29. Ac-33172
30. Vu0244552-7
31. Sr-01000000174-4
32. 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol,sulfuric Acid
| Molecular Weight | 323.36 g/mol |
|---|---|
| Molecular Formula | C12H21NO7S |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 323.10387318 g/mol |
| Monoisotopic Mass | 323.10387318 g/mol |
| Topological Polar Surface Area | 156 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 286 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Terbutaline sulfate |
| Drug Label | Terbutaline Sulfate, USP, the active ingredient of Terbutaline Sulfate Injection, USP, is a betaadrenergic agonist bronchodilator available as a sterile, nonpyrogenic, aqueous solution in vials, for subcutaneous administration. Each milliliter of... |
| Active Ingredient | Terbutaline sulfate |
| Dosage Form | Tablet; Injectable |
| Route | Injection; Oral |
| Strength | 2.5mg; 1mg/ml; 5mg |
| Market Status | Prescription |
| Company | Bedford; Hikma Farmaceutica; United Biomedcl; Fresenius Kabi Usa; Lannett; Impax Labs; Akorn |
| 2 of 2 | |
|---|---|
| Drug Name | Terbutaline sulfate |
| Drug Label | Terbutaline Sulfate, USP, the active ingredient of Terbutaline Sulfate Injection, USP, is a betaadrenergic agonist bronchodilator available as a sterile, nonpyrogenic, aqueous solution in vials, for subcutaneous administration. Each milliliter of... |
| Active Ingredient | Terbutaline sulfate |
| Dosage Form | Tablet; Injectable |
| Route | Injection; Oral |
| Strength | 2.5mg; 1mg/ml; 5mg |
| Market Status | Prescription |
| Company | Bedford; Hikma Farmaceutica; United Biomedcl; Fresenius Kabi Usa; Lannett; Impax Labs; Akorn |
Adrenergic beta-2 Receptor Agonists
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Tocolytic Agents
Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)
Market Place
